tirzepatide and naion Risk of Higher in Patients on GLP-1 Drugs for Diabetes or Weight Loss The ongoing debate of whether

Daily doses typically fell between 0.25 mg to 2.4 mg

This variability is normal and reflects fluctuations in water retention, hormonal cycles, sodium intake, and dozens of other factors that temporarily mask fat loss

Presented for research literature review only Kraemer WJ et al

The drugs yield an average weight loss of around 15 per cent, and weight can also rebound rapidly once the drugs are stopped

That distinction matters because many patients ask about Mounjaro for weight loss. Still, the medical conversation should be precise about the active ingredient, the brand, and the indication being evaluated by the clinician